Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Clinical

Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021

Kwame Amponsa-Achiano, Joseph Asamoah FrimpongComments to Author , Danielle Barradas, Delia Akosua Bandoh, and Ernest Kenu
Author affiliations: Expanded Program on Immunization, Ghana Health Service, Accra, Ghana (K. Amponsa-Achiano); Ghana Field Epidemiology and Laboratory Training Programme, University of Ghana, Accra (J.A. Frimpong, D.A. Bandoh, E. Kenu); US Centers for Disease Control and Prevention, Accra (D. Barradas)

Main Article

Table 2

Performance of phase 1 COVID-19 vaccine deployment, Ghana, March 1–August 23, 2021

Phase Start date No. regions No. districts Target segmentation No. doses administered
Phase 1A 2021 Mar 1 3 43 Most at-risk groups in 43 hotspot districts 535,408
Phase 1B 2021 Mar 24 13 217 All healthcare workers 316,639
Phase 1C 2021 May 19 3 43 All persons vaccinated in Phase 1A during March 1–9, 2021 (12 weeks after first dose) 380,829
Phase 1D 2021 Jun 20 16 260 2021 census enumerators (1st dose) and 2nd dose vaccinations in selected districts 65,034
Phase 1E
 2021 Aug 13
 3
 11
 General population in selected areas
 126,178
Total 1,424,088

Main Article

Page created: October 05, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external